1. Home
  2. TCRT vs SNES Comparison

TCRT vs SNES Comparison

Compare TCRT & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCRT
  • SNES
  • Stock Information
  • Founded
  • TCRT 1998
  • SNES 2004
  • Country
  • TCRT United States
  • SNES United States
  • Employees
  • TCRT N/A
  • SNES N/A
  • Industry
  • TCRT Biotechnology: Pharmaceutical Preparations
  • SNES Agricultural Chemicals
  • Sector
  • TCRT Health Care
  • SNES Industrials
  • Exchange
  • TCRT Nasdaq
  • SNES Nasdaq
  • Market Cap
  • TCRT 2.5M
  • SNES 2.3M
  • IPO Year
  • TCRT N/A
  • SNES 2016
  • Fundamental
  • Price
  • TCRT $3.08
  • SNES $1.70
  • Analyst Decision
  • TCRT
  • SNES Strong Buy
  • Analyst Count
  • TCRT 0
  • SNES 1
  • Target Price
  • TCRT N/A
  • SNES $10.00
  • AVG Volume (30 Days)
  • TCRT 946.1K
  • SNES 225.4K
  • Earning Date
  • TCRT 05-14-2025
  • SNES 03-12-2025
  • Dividend Yield
  • TCRT N/A
  • SNES N/A
  • EPS Growth
  • TCRT N/A
  • SNES N/A
  • EPS
  • TCRT N/A
  • SNES N/A
  • Revenue
  • TCRT $10,000.00
  • SNES $1,857,000.00
  • Revenue This Year
  • TCRT $5,680,500.00
  • SNES $130.53
  • Revenue Next Year
  • TCRT N/A
  • SNES $80.00
  • P/E Ratio
  • TCRT N/A
  • SNES N/A
  • Revenue Growth
  • TCRT 100.00
  • SNES 55.66
  • 52 Week Low
  • TCRT $1.31
  • SNES $1.72
  • 52 Week High
  • TCRT $18.50
  • SNES $9.80
  • Technical
  • Relative Strength Index (RSI)
  • TCRT 85.08
  • SNES 29.93
  • Support Level
  • TCRT $1.31
  • SNES $1.72
  • Resistance Level
  • TCRT $1.60
  • SNES $1.89
  • Average True Range (ATR)
  • TCRT 0.27
  • SNES 0.16
  • MACD
  • TCRT 0.16
  • SNES -0.02
  • Stochastic Oscillator
  • TCRT 87.12
  • SNES 5.95

About TCRT Alaunos Therapeutics Inc.

Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations.

About SNES SenesTech Inc.

SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.

Share on Social Networks: